Update
$Can-Fite BioPharma (CANF.US)$ Can-Fite: Pancreatic Carcinoma Phase IIa Clinical Study with Namodenoson Received Regulatory Authorization from the Israeli Ministry of Health
6 MINUTES AGO, 7:00 AM EDT
VIA GLOBENEWSWIRE
6 MINUTES AGO, 7:00 AM EDT
VIA GLOBENEWSWIRE
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
